Scientists test hormone blocker to fight severe insulin resistance

NCT ID NCT05470504

Recruiting now Disease control Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a drug that blocks growth hormone can help adults with severe insulin resistance caused by rare fat storage disorders. Participants will give themselves daily injections of the drug for one month while researchers measure how their bodies process fat and sugar. The goal is to see if this approach can reduce harmful fat breakdown and improve metabolic health.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RECEPTOR MUTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INSULIN RECEPTOR MUTATION PARTIAL LIPODYSTROPHY